tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

NVCR Stock Latest News

Ladenburg starts Novocure with a Buy, sees ‘path to profitability’
The FlyLadenburg starts Novocure with a Buy, sees ‘path to profitability’
10d ago
NVCR
Novocure initiated with a Buy at Ladenburg
PremiumThe Fly
Novocure initiated with a Buy at Ladenburg
10d ago
NVCR
Promising Phase 3 Results for NovoCure’s TTFields Therapy in Pancreatic Cancer
PremiumRatings
Promising Phase 3 Results for NovoCure’s TTFields Therapy in Pancreatic Cancer
16d ago
NVCR
Novocure to present final secondary endpoint results from PANOVA-3 trial
PremiumThe Fly
Novocure to present final secondary endpoint results from PANOVA-3 trial
17d ago
NVCR
Novocure management to meet with Piper Sandler
PremiumThe Fly
Novocure management to meet with Piper Sandler
1M ago
NVCR
NovoCure Appoints New President at Annual Meeting
PremiumCompany AnnouncementsNovoCure Appoints New President at Annual Meeting
1M ago
8K
NVCR
Novocure data support pancreatic cancer approval, says Wells Fargo
Premium
The Fly
Novocure data support pancreatic cancer approval, says Wells Fargo
2M ago
NVCR
NovoCure Announces Positive Phase 3 Trial Results
Premium
Company Announcements
NovoCure Announces Positive Phase 3 Trial Results
2M ago
8K
NVCR
Positive Buy Rating for NovoCure Driven by Promising PANOVA-3 Trial Results in Pancreatic Cancer Treatment
PremiumRatings
Positive Buy Rating for NovoCure Driven by Promising PANOVA-3 Trial Results in Pancreatic Cancer Treatment
2M ago
NVCR
Positive Outlook for NovoCure Amid Promising PANOVA-3 Trial Results and Anticipated FDA Approval
PremiumRatings
Positive Outlook for NovoCure Amid Promising PANOVA-3 Trial Results and Anticipated FDA Approval
2M ago
NVCR
Novocure announces results from Phase 3 PANOVA-3 trial
PremiumThe Fly
Novocure announces results from Phase 3 PANOVA-3 trial
2M ago
NVCR
NovoCure’s Strong Financial Performance and Promising Pipeline Drive Buy Rating
PremiumRatings
NovoCure’s Strong Financial Performance and Promising Pipeline Drive Buy Rating
3M ago
NVCR
Novocure’s Q1 2025: Revenue Growth and Strategic Advances
PremiumCompany AnnouncementsNovocure’s Q1 2025: Revenue Growth and Strategic Advances
3M ago
NVCR
NovoCure Ltd. Earnings Call: Growth Amid Financial Challenges
Premium
Company Announcements
NovoCure Ltd. Earnings Call: Growth Amid Financial Challenges
3M ago
NVCR
Novocure’s NSCLC launch momentum ‘positive,’ says H.C. Wainwright
Premium
The Fly
Novocure’s NSCLC launch momentum ‘positive,’ says H.C. Wainwright
3M ago
NVCR
NovoCure’s Strong Market Penetration and Promising Growth Prospects Justify Buy Rating
PremiumRatings
NovoCure’s Strong Market Penetration and Promising Growth Prospects Justify Buy Rating
3M ago
NVCR
Novocure reports Q1 EPS (31c), consensus (46c)
PremiumThe Fly
Novocure reports Q1 EPS (31c), consensus (46c)
3M ago
NVCR
Novocure to present Phase 3 PANOVA-3 trial results at ASCO 2025
PremiumThe Fly
Novocure to present Phase 3 PANOVA-3 trial results at ASCO 2025
3M ago
NVCR
Novocure price target lowered to $34 from $42 at Piper Sandler
PremiumThe Fly
Novocure price target lowered to $34 from $42 at Piper Sandler
3M ago
NVCR
Novocure announces CE Mark for Optune Lua
PremiumThe FlyNovocure announces CE Mark for Optune Lua
3M ago
NVCR
NovoCure’s Optune Lua Gains CE Mark Approval
Premium
Company Announcements
NovoCure’s Optune Lua Gains CE Mark Approval
3M ago
8K
NVCR
NovoCure Ltd. (NVCR) Q1 Earnings Cheat Sheet
Premium
Pre-Earnings
NovoCure Ltd. (NVCR) Q1 Earnings Cheat Sheet
3M ago
NVCR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >